Pearls on diabetes meds in perioperative care
Learn when to stop and start glucagon-like peptide-1 agonists, dipeptidyl peptidase-4 inhibitors, and sodium-glucose cotransporter-2 inhibitors.
During the perioperative medicine precourse at Internal Medicine Meeting 2023, Avital O’Glasser, MD, FACP, took attendees on a tour of type 2 diabetes medications. ACP Hospitalist coverage from the meeting offers guidance on how to manage three of the newer classes in patients undergoing noncardiac surgery: glucagon-like peptide-1 agonists, dipeptidyl peptidase-4 inhibitors, and sodium-glucose cotransporter-2 inhibitors.